Nabriva Therapeutics plc (NBRV) shares are trading at higher $0.61 and the avg recommendation for the stock is Moderate Buy.
To add more color to this target, the company’s high over the last year is $2.23 and the low is $0.49. Over the last 52 weeks, NBRV is down -68.27% while the S&P 500 is up 18.31%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, NBRV reported a profit of $0.12 million. Nabriva Therapeutics plc also saw revenues increase to $0.49 million. In addition, NBRV has free cash flow of -$45.46 million as of 06-2020. The company’s EBITDA came in at -$14.19 million which compares well with its peers.
NBRV Return on Equity (ROE) is -219.60%, and its Return on Assets is -109.60%. All told, it is clear that, NBRV needs to be on your watchlist.
Find out when NBRV reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. NBRV has a short ratio of 1.59 and outstanding shares of 143.96M.
NBRV has seen increased volume after this news and investors are putting their support behind the value proposition. Traders will also note the company’s earnings per share came in at -0.91. Nabriva Therapeutics plc NBRV also noted assets of $65.05 million at the end of the last quarter. Investors should also keep an eye on sector updates as NBRV has historically followed its peers on positive news.
All told, Nabriva Therapeutics plc NBRV has strung together solid data and demonstrated underlying fundamentals. At its current valuation, NBRV represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Nabriva Therapeutics plc NBRV is now commanding a market cap of 84.94M and a float of 142.06M. NBRV is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of NBRV stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in NBRV, either long or short, and we have not been compensated for this article.